Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-25.17%
↑ 56% above average
Average (9y)
-56.57%
Historical baseline
Range
High:127.12%
Low:-612.50%
CAGR
-15.0%
Structural decline
| Period | Value |
|---|---|
| 2024 | -25.17% |
| 2023 | -21.14% |
| 2022 | -612.50% |
| 2021 | 127.12% |
| 2020 | 3.80% |
| 2019 | 36.99% |
| 2018 | -0.69% |
| 2017 | 4.61% |
| 2016 | 29.47% |
| 2015 | -108.21% |